M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
- The Week’s Closed M&A Transactions:
- On September 2, 2025, High Tide Inc. (HITI: TSX), the sixth-largest Canadian cannabis operator based on market capitalization, closed the acquisition of a 51% interest in Remexian for an estimated purchase price of US$29.38 million.
- The consideration was composed of $8.51M cash, $12.35M in stock, and seller notes for the remaining $8.51M.
- Remexian’s owners also granted High Tide a call option to acquire the remaining interests not owned by High Tide. The call option has a 5-year maturity and is exercisable at an enterprise value of 4x trailing EBITDA if exercised in the first year and 3.64x if exercised thereafter.
- High Tide also granted Remexian a put option to put the remaining shares not owned by High Tide at an exercise price of 3.64x trailing EBITDA.
- The acquisition gives High Tide an entry into Germany, the largest European cannabis market.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.